Increased caspase-3 activity in refractory anemias: Lack of evidence for Fas pathway implication [9]

Leukemia

Volumn 16, Issue 11, 2002, Pages 2343-2345

  Boudard, D ^a   Sordet, O ^b   Piselli, S ^a   Viallet, A ^c   Guyotat, D ^a,c   Campos, L ^a,c  

^a UNIVERSITÉ JEAN MONNET   (France)

^b INSERM   (France)

^c UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CASPASE 3; CASPASE 8; ENZYME PRECURSOR; FAS ANTIGEN; FAS LIGAND; PROTEIN BID;

APOPTOSIS; BONE MARROW CELL; CELL CULTURE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME ACTIVITY; FLUOROMETRY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HYPOTHESIS; IN VITRO STUDY; INCUBATION TIME; LETTER; MONONUCLEAR CELL; MYELODYSPLASTIC SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; REFRACTORY ANEMIA; SIGNAL TRANSDUCTION;

EID: 0036848440     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402700     Document Type: Letter

References (7)

1. Boudard D, Sordet O, Vasselon C, Revol V, Bertheas MF, Freyssenet D, Viallet A, Piselli S, Guyotat D, Campos L. Expression and activity of caspases 1 and 3 in myelodysplastic syndromes. Leukemia 2000; 14: 2045-2051.
2. Bouscary D, De Vos J, Guesnu M, Jondeau K, Viguier F, Melle J, Picard F, Dreyfus F, Fontenay-Roupie M. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes. Leukemia 1997; 11: 839-845.
3. Gersuk GM, Beckham C, Loken MR, Kiener P, Anderson JE, Farrand A, Troutt AB, Ledbetter JA, Deeg HJ. A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome. Br J Haematol 1998; 103: 176-188.
4. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME. Two CD95 (APO-1/Fas) signaling pathways. EMBO J 1998; 17: 1675-1687.
5. Sordet O, Rebe C, Leroy I, Bruey JM, Garrido C, Miguet C, Lizard G, Plenchette S, Corcos L, Solary E. Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis. Blood 2001; 97: 3931-3940.
6. Hellstrom-Lindberg E, Schmidt-Mende J, Forsblom AM, Christensson B, Fadeel B, Zhivotovsky B. Apoptosis in refractory anaemia with ringed sideroblasts is initiated at the stem cell level and associated with increased activation of caspases. Br J Haematol 2001; 112: 714-726.
7. Gattermann N. From sideroblastic anemia to the role of mitochondrial DNA mutations in myelodysplastic syndromes. Leuk Res 2000; 24: 141-151.